Concepedia

Author

Richard Ventura

NGM Biopharmaceuticals (United States)ORCID

Also Known As

R. Ventura, R.G. Ventura, Richard Ventura

28

Publications

2.1K

Citations

9

H-Index

20

Concepts

All Affiliations

NGM Biopharmaceuticals (United States)Exelixis (United States)Pacific Biosciences (United States)Harvard University
RV

About

Richard Ventura is an author at NGM Biopharmaceuticals (United States) specializing in medicine, pharmacology, and liver physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

1.2K

2

Natural Sciences

1

1

843

3

Biology

1

1

843

4

Cell Biology

1

1

92

5

Cellular Physiology

1

1

92

Richard Ventura

×

9

Publications

2.1K

Citations

9

H-Index

YearCitations

A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac

Stephen T. Thibault, Matthew A. Singer, W Y Miyazaki,

Nature Genetics

2004

843

Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression

Richard Ventura, Kasia Mordec, Joanna Waszczuk,

EBioMedicine

2015

288

Lava Lamp, a Novel Peripheral Golgi Protein, Is Required for <i>Drosophila melanogaster</i> Cellularization

John C. Sisson, Christine M. Field, Richard Ventura,

The Journal of Cell Biology

2000

279

Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice

Rowena Suriben, Michael Chen, Jared Higbee,

Nature Medicine

2020

273

FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression

Timothy S. Heuer, Richard Ventura, Kasia Mordec,

EBioMedicine

2016

128

Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

Jui–Hsia Weng, Peter D. Koch, Harding H. Luan,

Nature Metabolism

2021

92

Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647

Steven Gendreau, Richard Ventura, Paul Keast,

Clinical Cancer Research

2007

89

The Fibronectin–ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells

Kevin J. Paavola, Julie M. Roda, Vicky Y. Lin,

Cancer Immunology Research

2021

60

Preclinical Characterization of PWT143, a Novel Selective and Potent Phosphatidylinositol 3-kinase Delta (PI3K delta) Inhibitor with Ex-Vivo Activity in Hematologic Malignancies.

Marie O’Farrell, Richard Ventura, Albert Tai,

Blood

2012

20

Page 1